The Role of miR-138 in Alzheimer's Disease Dendritic Spine Pathology
About the Research Project
Program
Award Type
Pilot
Award Amount
$150,000
Active Dates
April 01, 2010 - September 30, 2012
Grant ID
A2010385
Goals
We will test if dysregulation of the miR-138 controlled pathway contributes to dendritic spine pathology in a murine tauopathy model. We believe this project is highly innovative because if successful, this study will be one of the first to directly link the dysregulation of a miRNA regulated pathway to the in vivo dendritic spine pathology seen in a mouse model of human tauopathy.
Summary
We are going to investigate the role of an important class of regulatory proteins in Alzheimer’s disease. The success of this project may be beneficial to the public in the form of new treatment developments.
Related Grants
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University